APA (7th ed.) Citation

AF, L., KW, C., S, L., MD, H., LJ, H., ES, D., . . . JS, C. (2025). Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 80(6), 1235. https://doi.org/10.1093/cid/ciaf029

Chicago Style (17th ed.) Citation

AF, Luetkemeyer, et al. "Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 80, no. 6 (2025): 1235. https://doi.org/10.1093/cid/ciaf029.

MLA (9th ed.) Citation

AF, Luetkemeyer, et al. "Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 80, no. 6, 2025, p. 1235, https://doi.org/10.1093/cid/ciaf029.